| dc.contributor.author | Taylor, James M. | en |
| dc.contributor.author | Dunkerley, Sarah | en |
| dc.contributor.author | Silver, David A. | en |
| dc.contributor.author | Redfern, Andrew | en |
| dc.contributor.author | Talbot, Nick J. | en |
| dc.contributor.author | Sharpe, Ian T. | en |
| dc.contributor.author | Guyver, Paul M. | en |
| dc.date.accessioned | 2016-02-08T15:42:26Z | en |
| dc.date.available | 2016-02-08T15:42:26Z | en |
| dc.date.issued | 2016-03 | en |
| dc.identifier.citation | Extracorporeal shockwave therapy (ESWT) for refractory Achilles tendinopathy: A prospective audit with 2-year follow up. 2016, 26:23-29 Foot (Edinb) | en |
| dc.identifier.issn | 1532-2963 | en |
| dc.identifier.pmid | 26802946 | en |
| dc.identifier.doi | 10.1016/j.foot.2015.08.007 | en |
| dc.identifier.uri | http://hdl.handle.net/11287/595884 | en |
| dc.description.abstract | Achilles tendinopathy (AT) represents a triad of tendon pain, swelling and impaired performance. Extracorporeal shockwave therapy (ESWT) has been endorsed by the National Institute for Health and Care Excellence (NICE) for refractory AT. This audit investigates the long-term outcomes of patients treated with ESWT for refractory AT. | en |
| dc.language | ENG | en |
| dc.language.iso | en | en |
| dc.publisher | Elsevier | en |
| dc.relation.url | http://www.sciencedirect.com/science/article/pii/S095825921500084X | en |
| dc.rights | Archived with thanks to Foot (Edinburgh, Scotland) | en |
| dc.subject | Wessex Classification Subject Headings::Orthopaedics | en |
| dc.title | Extracorporeal shockwave therapy (ESWT) for refractory Achilles tendinopathy: A prospective audit with 2-year follow up. | en |
| dc.type | Journal Article | en |
| dc.identifier.journal | Foot (Edinburgh, Scotland) | en |
| dc.type.version | Published | en |
| dc.description.admin-note | Accepted manuscript, 12 month embargo, CC-BY-NC-ND | en |
